Featured news in The Life Sciences Report

Caladrius Biosciences Inc. (CLBS:NASDAQ)
Caladrius Biosciences to Host 2018 Fourth Quarter and Year End Financial Results Conference Call on Thursday, March 14, 2019 at 4:30 p.m. Eastern Time (3/13/2019)
view
 


Celgene Corp. (CELG:NASDAQ)
Biotech Stock Roundup: REGN Gets FDA Nod for Dupixent & Other Pipeline News (3/13/2019)
view
 

Celgene Corp. (CELG:NASDAQ)
Advancing Clinical Trials For Leukemia Patients Is Helping Improve Survival Rate (3/14/2019)
view
 

Celgene Corp. (CELG:NASDAQ)
Aerie (AERI) Receives FDA Nod for Rocklatan to Treat Glaucoma (3/13/2019)
view
 

Celgene Corp. (CELG:NASDAQ)
Top Ranked Value Stocks to Buy for March 14th (3/14/2019)
view
 


BrainStorm Cell Therapeutics Inc. (BCLI:NASDAQ)
BrainStorm Announces First Patient Enrolled in Phase 2 Clinical Trial of Progressive MS (3/14/2019)
view
 


Celgene Corp. (CELG:NASDAQ)
Regeneron/Sanofi's Dupixent Gets FDA Nod for Label Expansion (3/12/2019)
view
 

Celgene Corp. (CELG:NASDAQ)
CELG vs. VRTX: Which Stock Is the Better Value Option? (3/13/2019)
view
 

Celgene Corp. (CELG:NASDAQ)
Zacks.com featured expert Kevin Matras highlights: Sallie Mae, United Continental, Celgene and Ligand Pharmaceuticals (3/13/2019)
view
 


Mesoblast Ltd. (MESO:NASDAQ; MSB:ASX)
Mesoblast Features at Upcoming U.S. Investor Conferences (3/13/2019)
view
 


BrainStorm Cell Therapeutics Inc. (BCLI:NASDAQ)
VIDEO: BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI) (3/13/2019)
view
 


Celgene Corp. (CELG:NASDAQ)
Top Ranked Value Stocks to Buy for March 11th (3/11/2019)
view
 

Celgene Corp. (CELG:NASDAQ)
Roche's (RHHBY) Tecentriq Gets FDA Approval for Breast Cancer (3/12/2019)
view
 

Celgene Corp. (CELG:NASDAQ)
AMAG's Stock Down as Pregnancy Drug Fails in PROLONG Study (3/11/2019)
view
 

Celgene Corp. (CELG:NASDAQ)
4 High Earnings Yield Stocks to Strengthen Your Portfolio (3/12/2019)
view
 

Celgene Corp. (CELG:NASDAQ)
Alnylam Files Application for Hypertension Candidate in UK (3/12/2019)
view